Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Middle Aortic Syndrome and Renal Artery Stenosis: Disease Beyond the Arch
EF 2013-14
Résumé
Middle aortic syndrome is a rare disease that occurs in children and young adults and presents with narrowing of the largest blood vessel, the aorta and also narrowing of the blood vessels to the kidney (renal artery stenosis). Middle aortic syndrome and narrowing of the kidney vessels typically manifests as uncontrolled high blood pressure in children and can lead to life threatening complications such as thickening of the heart muscle, stroke, heart disease and heart failure. If left untreated, patients may die before the age of 40 due to complications. The exact cause of this syndrome is unknown, some studies suggest that middle aortic syndrome is an inherited disorder while others hypothesize that is it an acquired disease. There have been few studies on the risk factors leading to narrowing of these major blood vessels in children. The current management approach is to treat these children with medication to control their high blood pressure, but some of them do not respond to these medications and require surgery. There is high variability in the symptoms and severity of disease among patients. Without an understanding of the changes in the blood vessels that cause the disease, we can't make important decisions regarding the management of these patients. These include choice of blood pressure medications and timing of surgery.
We plan to address this gap in knowledge by establishing a study of all children with middle aortic syndrome and narrowing of the kidney vessels at the Hospital for Sick Children. We will collect information on these children over time, including the severity of the disease, and the different vessels involved. We will also characterize the heart and vessel disease in children by performing state of the art imaging, and looking at validated measures of changes in blood vessel structure. This will allow us to understand the changes in the heart and blood vessels, and target those changes in the treatment of patients. In addition, we will compare the properties of the blood vessels between children with middle aortic syndrome and a group of healthy children.
A better understanding of this disease process will improve diagnosis and management of patients with middle aortic syndrome and narrowing of the kidney vessels. Investigating the changes in the blood vessels will help us understand the cause of high blood pressure in children, and may lead to the identification of factors that lead to worsening of the disease. We can use this knowledge to identify the disease in the early stages, manage patients more effectively, and avoid the complications caused by the high blood pressure.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
312049
Name
Rumman Rawan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Middle Aortic Syndrome and Renal Artery Stenosis: Disease Beyond the Arch
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clinical Phenotype; Middle Aortic Syndrome; Prospective Study; Refractory Hypertension; Renal Artery Stenosis; Vascular Phenotype
Abstract
Middle aortic syndrome is a rare disease that occurs in children and young adults and presents with narrowing of the largest blood vessel, the aorta and also narrowing of the blood vessels to the kidney (renal artery stenosis). Middle aortic syndrome and narrowing of the kidney vessels typically manifests as uncontrolled high blood pressure in children and can lead to life threatening complications such as thickening of the heart muscle, stroke, heart disease and heart failure. If left untreated, patients may die before the age of 40 due to complications. The exact cause of this syndrome is unknown, some studies suggest that middle aortic syndrome is an inherited disorder while others hypothesize that is it an acquired disease. There have been few studies on the risk factors leading to narrowing of these major blood vessels in children. The current management approach is to treat these children with medication to control their high blood pressure, but some of them do not respond to these medications and require surgery. There is high variability in the symptoms and severity of disease among patients. Without an understanding of the changes in the blood vessels that cause the disease, we can't make important decisions regarding the management of these patients. These include choice of blood pressure medications and timing of surgery.
We plan to address this gap in knowledge by establishing a study of all children with middle aortic syndrome and narrowing of the kidney vessels at the Hospital for Sick Children. We will collect information on these children over time, including the severity of the disease, and the different vessels involved. We will also characterize the heart and vessel disease in children by performing state of the art imaging, and looking at validated measures of changes in blood vessel structure. This will allow us to understand the changes in the heart and blood vessels, and target those changes in the treatment of patients. In addition, we will compare the properties of the blood vessels between children with middle aortic syndrome and a group of healthy children.
A better understanding of this disease process will improve diagnosis and management of patients with middle aortic syndrome and narrowing of the kidney vessels. Investigating the changes in the blood vessels will help us understand the cause of high blood pressure in children, and may lead to the identification of factors that lead to worsening of the disease. We can use this knowledge to identify the disease in the early stages, manage patients more effectively, and avoid the complications caused by the high blood pressure.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rumman, Rawan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~